Search results
New drug for cervical cancer patients approved for use in NHS in Scotland
Press Association News via AOL· 1 year agoScotland has become the the first part of the UK to make a new treatment for women with advanced...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 10 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoThe European Commission (EC) has granted Bristol Myers Squibb (BMS) approval for its Opdivo...
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
Benzinga via Yahoo Finance· 2 years agoNanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime...
New ways to treat bladder cancer improve survival and shake up the standard of care, new studies...
CNN via Yahoo News· 8 months agoA new combination of cancer medications has been shown in research to extend overall survival in...
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian...
Benzinga via Yahoo Finance· 2 years agoSELLAS Life Sciences Group Inc (NASDAQ: SLS) announced confirmatory topline data from the final...
OncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For...
Benzinga via Yahoo Finance· 1 year agoOncoSec Medical Incorporated (NASDAQ: ONCS) shares plummeted Monday following Phase 2 KEYNOTE-695...
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 3 days agoBright Peak Therapeutics has raised $90m in a Series C financing round as the biotech looks to make...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Gilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Study
Zacks via Yahoo Finance· 1 year agoGilead Sciences, Inc. GILD and partner Arcus Biosciences, Inc. RCUS announced encouraging updated...